Oncology & Cancer

Age, life expectancy influence termination of PSA screening

(HealthDay) -- Most primary care providers consider both a man's age and life expectancy in deciding whether to discontinue prostate-specific antigen (PSA) screenings, but multiple factors are involved in this decision, according ...

Oncology & Cancer

A new screening method for prostate cancer

A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically ...

page 22 from 33